Wood Gavin 4
4 · Adaptimmune Therapeutics PLC · Filed Dec 16, 2020
Insider Transaction Report
Form 4
Wood Gavin
Chief Financial Officer
Transactions
- Purchase
Ordinary Shares with a nominal value of GBP0.001 per share
2020-12-14$0.69/sh+24,000$16,550→ 57,000 total
Footnotes (4)
- [F1]The ordinary shares whose purchase is reported on this line are represented by American Depositary Shares ("ADS") and are held in the form of ADSs by Gavin Wood. Each ADS represents six ordinary shares of Adaptimmune Therapeutics plc.
- [F2]The 24,000 ordinary shares reported in Column 4 are represented by 4,000 ADSs.
- [F3]The price reported in Column 4 of $0.6896 per ordinary share is derived from the purchase price paid on December 14, 2020 of $4.1375 per ADS divided by six.
- [F4]The 57,000 ordinary shares reported in Column 5 include 33,000 ordinary shares represented by 5,500 ADSs owned by Mr. Wood prior to the purchase reported in Column 4. These shares are held in the form of ADSs by Mr. Wood.